Phospholamban deficiency alters inactivation kinetics of L-type Ca2+ channels in mouse ventricular myocytes

Am J Physiol. 1997 Feb;272(2 Pt 2):H606-12. doi: 10.1152/ajpheart.1997.272.2.H606.

Abstract

Entry of Ca2+ through voltage-dependent L-type Ca2+ channels is critical for contraction in cardiac cells. In recent studies, cells from phospholamban (PLB) knockout (PLB-KO) mouse hearts showed significantly increased basal contractility with enhanced sarcoplasmic reticulum (SR) Ca2+ uptake. To test whether these effects of PLB ablation were associated with alterations of L-type Ca2+ channel function, we compared the properties of Ca2+ channel currents (I(Ca)) in ventricular myocytes isolated from wild-type (WT) and PLB-KO mouse hearts. L-type Ca2+ channels from mouse myocytes exhibited voltage-dependent gating and sensitivity to dihydropyridine drugs, similar to other mammalian species, and these properties were not altered by PLB ablation. I(Ca) from both WT and PLB-KO cells revealed two (fast and slow) components of inactivation kinetics. However, the proportion of the faster component was significantly larger in PLB-KO cells. Ryanodine (10 microM) reduced the rate of inactivation of I(Ca) for both WT and PLB-KO cells, but the reduction was more prominent in PLB-KO cells compared with WT cells. In contrast, the inactivation in a Ba2+ solution could be fitted by a single exponential similar to the slower component in Ca2+, and this was not altered in PLB-KO cells. The increase in the fast Ca2+-dependent inactivation component in PLB-KO cells supports the hypothesis that Ca2+ released from the SR regulates Ca2+ channel inactivation by affecting the levels of Ca2+ near the channel and suggests that this may be an important compensatory mechanism in the hyperdynamic PLB-KO heart.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Calcium Channels / drug effects
  • Calcium Channels / physiology*
  • Calcium-Binding Proteins / deficiency*
  • Dihydropyridines / pharmacology
  • Heart Ventricles
  • Kinetics
  • Mice
  • Mice, Transgenic
  • Myocardium / cytology
  • Myocardium / metabolism*
  • Patch-Clamp Techniques
  • Time Factors

Substances

  • Calcium Channels
  • Calcium-Binding Proteins
  • Dihydropyridines
  • phospholamban